Biocure Technology, Inc. (CURE.X.CX)
0.04
-0.02
(-38.46%)
CAD |
CNSX |
Feb 10, 16:00
Biocure Technology Shareholders Equity (Quarterly) : 1.604M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -3.882M |
| Core One Labs, Inc. | -- |
| Resverlogix Corp. | -123.69M |
| Microbix Biosystems, Inc. | 27.79M |
| Theratechnologies, Inc. | -38.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.018M |
| Total Liabilities (Quarterly) | 0.4131M |
| Debt to Equity Ratio | 0.0351 |
| Current Ratio | 0.1457 |
| Net Debt Paydown Yield | -0.11% |